Musk’s startup to help treat these neurological disorders

Legendary businessman Elon Musk’s neuroscience startup Neuralink on Friday introduced a pig with a coin-sized electronic chip in his brain for two months, showing an early move toward the goal of Treating human disorders using the same form of implant. San Francisco-based Neuralink, co-founded by Musk in 2016, plans to insert wireless brain-computer interfaces that contain thousands of electrodes in the most complex human organ to help treat neurological disorders such as Alzheimer’s, dementia, and trauma to the spinal cord and eventually merge artificial intelligence with humanity.

Tesla CEO Elon Musk on Monday said his brain-computer-interface company Neuralink could be launching human trials by the end of 2021. “Neuralink is working super hard to ensure implant safety & is in close communication with the FDA,” Musk tweeted. In 2019.

Musk stated, “An implantable device can solve these problems,” on the webcast Friday, citing disorders such as memory loss, hearing loss, depression, and insomnia.

Also, he mentioned, “We’re not trying to raise money, We’re trying to convince great people to come work at Neuralink.”

Neuralink obtained $158 million in funding, of which $100 million came from Musk, and employs approximately 100 staff members, according to LinkedIn reports.

During the Neuralink conference in July 2019, Musk confirmed that the company was pursuing regulatory approval to introduce its product in clinical trials by the end of this year. Further than healthcare, Musk, who also worries about the dangers of artificial intelligence, said the implant will “secure humanity’s future as a civilization relative to AI.”

Musk identified the Neuralink detector, which is approximately eight millimeters (three-tenths of an inch) in diameter or less than a fingertip, as “a Fitbit in your skull with tiny wires.”

With the aid of a specialized robot, lightweight threads or wires thinner than a human hair are inserted in brain regions responsible for motor and sensory functions, when the receiver is under local anesthesia alone. The system is reversible, said Musk.

“Everyone in the field would be very impressed if they actually showed data from a device implanted in a human,” says Graeme Moffat, a research fellow at the University of Toronto.